Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio- economic status, Barcelona, Spain, 24 February to 4 May 2020


Por: Politi, J, Martin-Sanchez, M, Mercuriali, L, Borras-Bermejo, B, Lopez-Contreras, J, Vilella, A, Villar, J, Orcau, A, de Olalla, PG, Rius, C, Fernández, A., Puigpinós R., Bonfill X., Villalbí J.R.

Publicada: 20 may 2021
Resumen:
Background: Population-based studies characteris-ing outcomes of COVID-19 in European settings are limited, and effects of socio-economic status (SES) on outcomes have not been widely investigated. Aim: We describe the epidemiological characteristics of COVID-19 cases, highlighting incidence and mortal-ity rate differences across SES during the first wave in Barcelona, Catalonia, Spain. Methods: This popula-tion-based study reports individual-level data of lab-oratory-confirmed COVID-19 cases diagnosed from 24 February to 4 May 2020, notified to the Public Health Agency of Barcelona and followed until 15 June 2020. We analysed end-of-study vital status and the effects of chronic conditions on mortality using logistic regression. Geocoded addresses were linked to basic health area SES data, estimated using the composed socio-economic index. We estimated age-standard-ised incidence, hospitalisation, and mortality rates by SES. Results: Of 15,554 COVID-19-confirmed cases, the majority were women (n = 9,028; 58%), median age was 63 years (interquartile range: 46-83), 8,046 (54%) required hospitalisation, and 2,287 (15%) cases died. Prevalence of chronic conditions varied across SES, and multiple chronic conditions increased risk of death (>= 3, adjusted odds ratio: 2.3). Age-standardised rates (incidence, hospitalisation, mortality) were high-est in the most deprived SES quartile (incidence: 1,011 (95% confidence interval (CI): 975-1,047); hospitali-sation: 619 (95% CI: 591-648); mortality: 150 (95% CI: 136-165)) and lowest in the most affluent (inci-dence: 784 (95% CI: 759-809); hospitalisation: 400 (95% CI: 382-418); mortality: 121 (95% CI: 112-131)). Conclusions: COVID-19 outcomes varied markedly across SES, underscoring the need to implement effec-tive preventive strategies for vulnerable populations.

Filiaciones:
Politi, J:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain

 Pompeu Fabra Univ, Prevent Med & Publ Hlth Training Unit, PSMar UPF PHAB Parc Salut Mar, Publ Hlth Agcy Barcelona, Barcelona, Spain

Martin-Sanchez, M:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain

 Pompeu Fabra Univ, Prevent Med & Publ Hlth Training Unit, PSMar UPF PHAB Parc Salut Mar, Publ Hlth Agcy Barcelona, Barcelona, Spain

Mercuriali, L:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain

Borras-Bermejo, B:
 Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Prevent Med & Epidemiol, Barcelona, Spain

Lopez-Contreras, J:
 Univ Autonoma Barcelona, Hosp St Pau, Infect Dis Internal Med, Barcelona, Spain

Vilella, A:
 Hosp Clin Barcelona, Prevent Med & Epidemiol Dept, Barcelona, Spain

Villar, J:
 Hosp Mar, Serv Infect Dis, Barcelona, Spain

Orcau, A:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain

 Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain

de Olalla, PG:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain

 Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain

 Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain

Rius, C:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain

 Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Pediat Obstet Gynecol Prevent Med & Publ Hlt, Barcelona, Spain

Fernández, A.:
 Agència de Salut Pública de Barcelona, Barcelona, Spain

 Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain

Puigpinós R.:
 CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain

 Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain

Bonfill X.:
 Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain

Villalbí J.R.:
 Publ Hlth Agcy Barcelona PHAB, Epidemiol Serv, Barcelona, Spain
ISSN: 1025496X
Editorial
EUR CENTRE DIS PREVENTION & CONTROL, TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN, Suecia
Tipo de documento: Article
Volumen: 26 Número: 20
Páginas:
WOS Id: 000653091900001
ID de PubMed: 34018483
imagen Green Published, gold

MÉTRICAS